Anant Labdhi Exports

Country/Region: India

Company Introduction
Our hypertension high blood pressure goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in Surat, , India, laced with all the required amenities to keep the hypertension high blood pressure quality consistent and maintained. Buyers can reach us for acquiring first in class Eplerenone,Telmisartan,Rosuvastatin,Perindopril, as we are enlisted among best in class Manufacturers since 2012.Entire product line from Anant Labdhi Exports LLC (Limited Liability Corp) are made available in different variations with quality commitments that has no match, making our hypertension high blood pressure and Eplerenone,Telmisartan,Rosuvastatin,Perindopril highly demanded in the international market. Owing to which our export ratio value has reached US$50 Million - US$100 Million based on China,Spain,India,Japan,Turkey market share. Being a quality-conscious entity and a leading Supplier of hypertension high blood pressure, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 8 Years of export history led us to acquire Approx More Than 1 Billion US Dollar of yearly output.Our professional enterprise was first launched with US$50 Million - US$100 Million of initial investment under Agency.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2012, 2012

Legal Status: Agency

Ownership: LLC (Limited Liability Corp)

Employees: 201 - 300 People

Factory Size: 30, 000-50, 000 square meters

R&D Team Size: 11 - 50 People

Certifications: ISO13485

Contact Information

Contact Person: Vivek Shah

Designation: Manager

Department: Owner

Telephone: 91919898597084

Business Information

Main Markets: China (30%) Spain (28%) Turkey (25%) Japan (24%) India (20%)

Export Focus: China, Spain, India, Japan, Turkey

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: US$50 Million - US$100 Million

Export Percentage: 71% - 80%

Payment Terms: Bank wire (T/T)

Product Showcase
Eplerenone
Telmisartan
Rosuvastatin
Perindopril
Perindopril
Rosuvastatin
Eplerenone
Telmisartan

CL-Link > Health & Medicines in India Medicines in India Eplerenone in India